These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33029199)

  • 1. Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents.
    Kim SY; An S; Park DK; Kwon KA; Kim KO; Chung JW; Kim JH; Kim YJ
    Therap Adv Gastroenterol; 2020; 13():1756284820961302. PubMed ID: 33029199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.
    Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
    Inflamm Bowel Dis; 2015 Jul; 21(7):1587-93. PubMed ID: 25933393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease.
    Lucendo AJ; Roncero Ó; Serrano-Duenas MT; Hervías D; Alcázar LM; Miriam-Ruiz-Ponce ; Verdejo C; Laserna-Mendieta E; Lorente R; Arias Á
    Dig Liver Dis; 2020 Apr; 52(4):400-407. PubMed ID: 31892506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effects of anti-TNF agents on hemoglobin levels in patients with inflammatory bowel disease.
    Okuyucu M; Avcioğlu U; Şenel T; Ustaoğlu M
    Medicine (Baltimore); 2022 Sep; 101(35):e30118. PubMed ID: 36107528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-
    Shu W; Pang Z; Xu C; Lin J; Li G; Wu W; Sun S; Li J; Li X; Liu Z
    Mediators Inflamm; 2019; 2019():4038619. PubMed ID: 31814801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Anemia in Patients with Inflammatory Bowel Disease (IBD).
    Patel D; Trivedi C; Khan N
    Curr Treat Options Gastroenterol; 2018 Mar; 16(1):112-128. PubMed ID: 29404920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study.
    Vernero M; Boano V; Ribaldone DG; Pellicano R; Astegiano M
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):200-203. PubMed ID: 30917629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Risk Factors of Anemia in Inflammatory Bowel Diseases: A Case-Control Study.
    Aslam T; Mehmood A
    Cureus; 2023 Jul; 15(7):e41990. PubMed ID: 37593267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study.
    Foteinogiannopoulou K; Karmiris K; Axiaris G; Velegraki M; Gklavas A; Kapizioni C; Karageorgos C; Kateri C; Katsoula A; Kokkotis G; Koureta E; Lamouri C; Markopoulos P; Palatianou M; Pastras P; Fasoulas K; Giouleme O; Zampeli E; Theodoropoulou A; Theocharis G; Thomopoulos K; Karatzas P; Katsanos KH; Kapsoritakis A; Kourikou A; Mathou N; Manolakopoulos S; Michalopoulos G; Michopoulos S; Boubonaris A; Bamias G; Papadopoulos V; Papatheodoridis G; Papaconstantinou I; Pachiadakis I; Soufleris K; Tzouvala M; Triantos C; Tsironi E; Christodoulou DK; Koutroubakis IE;
    BMC Gastroenterol; 2021 Jun; 21(1):269. PubMed ID: 34187376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Duration, and Management of Anemia: A Nationwide Comparison Between IBD and Non-IBD Populations.
    Patel D; Yang YX; Trivedi C; Kavani H; Xie D; Medvedeva E; Lewis J; Khan N
    Inflamm Bowel Dis; 2020 May; 26(6):934-940. PubMed ID: 31560755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
    Beigel F; Löhr B; Laubender RP; Tillack C; Schnitzler F; Breiteneicher S; Weidinger M; Göke B; Seiderer J; Ochsenkühn T; Brand S
    Digestion; 2012; 85(1):47-54. PubMed ID: 22179489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
    Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
    Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.
    Wells CW; Lewis S; Barton JR; Corbett S
    Inflamm Bowel Dis; 2006 Feb; 12(2):123-30. PubMed ID: 16432377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia.
    Abbati G; Incerti F; Boarini C; Pileri F; Bocchi D; Ventura P; Buzzetti E; Pietrangelo A
    Intern Emerg Med; 2019 Apr; 14(3):423-431. PubMed ID: 30499070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
    Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
    Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).
    Reinisch W; Staun M; Tandon RK; Altorjay I; Thillainayagam AV; Gratzer C; Nijhawan S; Thomsen LL
    Am J Gastroenterol; 2013 Dec; 108(12):1877-88. PubMed ID: 24145678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on biochemical facet of anemia in cancers: A strong link between erythropoietin and tumor necrosis factor alpha in anemic cancer patients.
    Kalyani P; Jamil K
    Indian J Cancer; 2015; 52(1):127-32. PubMed ID: 26838000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate Prevents the Pathogenic Anemia-Inflammation Circuit by Facilitating Macrophage Iron Export.
    Xiao P; Cai X; Zhang Z; Guo K; Ke Y; Hu Z; Song Z; Zhao Y; Yao L; Shen M; Li J; Huang Y; Ye L; Huang L; Zhang Y; Liu R; Xu M; Xu X; Zhao Y; Cao Q
    Adv Sci (Weinh); 2024 Mar; 11(12):e2306571. PubMed ID: 38235606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Valério de Azevedo S; Maltez C; Lopes AI
    Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.